scispace - formally typeset
T

Thierry Poynard

Researcher at University of Paris

Publications -  679
Citations -  67161

Thierry Poynard is an academic researcher from University of Paris. The author has contributed to research in topics: Cirrhosis & Hepatitis C. The author has an hindex of 119, co-authored 668 publications receiving 64548 citations. Previous affiliations of Thierry Poynard include Paris Descartes University & Institute of Chartered Accountants of Nigeria.

Papers
More filters
Journal ArticleDOI

An algorithm for the grading of activity in chronic hepatitis C

Pierre Bedossa, +1 more
- 01 Aug 1996 - 
TL;DR: A simple algorithm that generates a single activity score based on basic pathological features in chronic hepatitis C is proposed and tested, showing its accuracy is as high as that obtained using a statistical approach.
Journal ArticleDOI

Natural history of liver fibrosis progression in patients with chronic hepatitis C

Thierry Poynard, +2 more
- 22 Mar 1997 - 
TL;DR: The host factors of ageing, alcohol consumption, and male sex have a stronger association with fibrosis progression than virological factors in HCV infection.
Journal ArticleDOI

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Thierry Poynard, +10 more
- 31 Oct 1998 - 
TL;DR: AnInterferon α2b plus ribavirin combination is more effective than 48 weeks of interferonα2b monotherapy and has an acceptable safety profile and patients with few favourable factors benefit more from extending the duration of combination therapy to 48 weeks.
Journal ArticleDOI

Viral hepatitis B

Ching-Lung Lai, +3 more
- 20 Dec 2003 - 
TL;DR: Current available monotherapies-interferon, lamivudine, and adefovir dipivoxil-very rarely eradicate the virus, but greatly reduce its replication, necroinflammatory histological activity, and progression of fibrosis.
Journal ArticleDOI

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.

Vlad Ratziu, +8 more
- 01 Jun 2005 - 
TL;DR: Histologic lesions of NASH are unevenly distributed throughout the liver parenchyma; therefore, sampling error of liver biopsy can result in substantial misdiagnosis and staging inaccuracies.